Rockwell Medical (RMTI) Debt to Equity: 2013-2025
Historic Debt to Equity for Rockwell Medical (RMTI) over the last 9 years, with Sep 2025 value amounting to $0.28.
- Rockwell Medical's Debt to Equity fell 22.19% to $0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.28, marking a year-over-year decrease of 22.19%. This contributed to the annual value of $0.33 for FY2024, which is 34.36% down from last year.
- Per Rockwell Medical's latest filing, its Debt to Equity stood at $0.28 for Q3 2025, which was down 22.36% from $0.37 recorded in Q2 2025.
- Rockwell Medical's 5-year Debt to Equity high stood at $8.11 for Q4 2021, and its period low was -$3.83 during Q1 2022.
- Over the past 3 years, Rockwell Medical's median Debt to Equity value was $0.42 (recorded in 2023), while the average stood at $0.48.
- Its Debt to Equity has fluctuated over the past 5 years, first spiked by 1,215.13% in 2021, then crashed by 573.02% in 2022.
- Rockwell Medical's Debt to Equity (Quarterly) stood at $8.11 in 2021, then slumped by 91.97% to $0.65 in 2022, then decreased by 22.16% to $0.51 in 2023, then crashed by 34.36% to $0.33 in 2024, then dropped by 22.19% to $0.28 in 2025.
- Its Debt to Equity stands at $0.28 for Q3 2025, versus $0.37 for Q2 2025 and $0.35 for Q1 2025.